Bank of New York Mellon’s 1Life Healthcare ONEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,958,170
| Closed | -$49.4M | – | 4479 |
|
|
2022
Q4 | $49.4M | Sell |
2,958,170
-1,681,734
| -36% | -$28.4M | 0.01% | 983 |
|
|
2022
Q3 | $79.6M | Sell |
4,639,904
-530,184
| -10% | -$8.32M | 0.02% | 678 |
|
|
2022
Q2 | $40.5M | Sell |
5,170,088
-171,206
| -3% | -$1.47M | 0.01% | 1116 |
|
|
2022
Q1 | $59.2M | Sell |
5,341,294
-161,294
| -3% | -$1.81M | 0.01% | 990 |
|
|
2021
Q4 | $96.7M | Buy |
5,502,588
+975,651
| +22% | +$18.9M | 0.02% | 721 |
|
|
2021
Q3 | $91.7M | Buy |
4,526,937
+1,739
| +0% | +$44.7K | 0.02% | 732 |
|
|
2021
Q2 | $150M | Buy |
4,525,198
+1,026,436
| +29% | +$38.7M | 0.03% | 519 |
|
|
2021
Q1 | $137M | Buy |
3,498,762
+945,480
| +37% | +$44.4M | 0.03% | 554 |
|
|
2020
Q4 | $111M | Buy |
2,553,282
+122,999
| +5% | +$4.2M | 0.02% | 610 |
|
|
2020
Q3 | $68.9M | Buy |
2,430,283
+268,962
| +12% | +$8.49M | 0.02% | 725 |
|
|
2020
Q2 | $78.5M | Buy |
2,161,321
+146,853
| +7% | +$4.14M | 0.02% | 648 |
|
|
2020
Q1 | $36.6M | Buy |
+2,014,468
| New | +$44.2M | 0.01% | 928 |
|
Bank of New York Mellon's ONEM Position: Q1 2023 in Review
Bank of New York Mellon sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 2,958,170 shares — an estimated $49.4M sold.
Bank of New York Mellon first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $150M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.
- Bank of New York Mellon reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
- Bank of New York Mellon sold 2,958,170 1Life Healthcare shares in Q1 2023, an estimated $49.4M.
- Bank of New York Mellon first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
- Bank of New York Mellon's 1Life Healthcare position peaked at $150M in Q2 2021.
- 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.